查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056320

免疫診斷市場報告：按產品、技術、應用、最終用戶和地區分類（2026-2034 年）

Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年全球免疫診斷市場規模達213億美元。展望未來，IMARC Group預測，從2026年到2034年，該市場將以6.25%的複合年成長率成長，到2034年達到374億美元。

免疫診斷是指利用抗原-抗體反應檢測感染疾病和慢性疾病的體外診斷技術。這包括使用輻射、螢光或顯色酶和探針來識別抗體，從而擴大疾病進展的檢測標靶範圍。免疫診斷也利用各種試劑、儀器和軟體解決方案，例如酵素免疫分析法(ELISA)、化學冷光、免疫測量和快速檢測。這些解決方案廣泛應用於癌症、自體免疫疾病、呼吸系統疾病、內分泌疾病和腫瘤等疾病的診斷，以及法醫學、環境分析和食品分析等領域。因此，免疫診斷的應用範圍十分廣泛，涵蓋醫院、臨床檢查室、研究機構和學術機構等許多領域。

免疫診斷市場趨勢：

慢性病和感染疾病在人群中的日益普遍是市場成長的主要驅動力。此外，老年人口的成長（他們更容易感染這些疾病）也促進了市場成長。消費者對B型肝炎、糖尿病和癌症等疾病治療方法方案的認知度不斷提高，也對免疫診斷試劑、檢測方法和分析儀器的需求產生了積極影響。此外，各種技術進步，例如下一代免疫診斷平台的開發，預計也將推動市場成長。這些先進的即時檢測（POC​​T）系統為敗血症、急性心肌梗塞和其他高死亡率疾病提供了更精密的診斷能力。預計推動市場成長的其他因素還包括公眾對個人化醫療日益成長的需求以及醫療基礎設施的顯著改善，尤其是在開發中國家。

本報告解答的主要問題

  • 全球免疫診斷市場規模有多大？
  • 2026年至2034年全球免疫診斷市場的預期成長率為何？
  • 全球免疫診斷市場的主要促進因素是什麼？
  • 新冠疫情對全球免疫診斷市場產生了哪些影響？
  • 從應用領域來看，全球免疫診斷市場是如何分類的？
  • 全球免疫診斷市場依最終用戶分類的組成是怎樣的？
  • 全球免疫診斷市場的主要區域有哪些？
  • 全球免疫診斷市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球免疫診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 試劑
  • 裝置
  • 軟體和服務

第7章 市場區隔：依技術分類

  • 酵素免疫分析法
  • 化學冷光免疫檢測
  • 螢光免疫分析
  • 免疫測量
  • 快速檢測
  • 其他

第8章 市場區隔：依應用領域分類

  • 感染疾病
  • 腫瘤學和內分泌學
  • 肝炎和逆轉錄病毒
  • 骨骼和礦物質
  • 自體免疫
  • 心臟生物標記
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 臨床實驗室
  • 學術和研究機構
  • 製藥和生物技術產業
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Arkray Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG
    • Immunodiagnostic Systems Holdings PLC
    • Johnson & Johnson
    • Siemens AG
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4249

The global immunodiagnostics market size reached USD 21.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 37.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.25% during 2026-2034.

Immunodiagnostics refers to an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It involves the use of radiological, fluorescent or color-forming enzymes and probes for the identification of antibodies that aid in enhancing the targeting range to identify disease progression. Immunodiagnostics also uses various reagents, instruments and software-based solutions for enzyme-linked immunosorbent assay, chemiluminescence, radioimmunoassay and rapid testing. These solutions are widely used for diagnosing diseases, such as cancer and autoimmune, respiratory, endocrine and oncological disorders, along with forensic psychology and environmental and food analysis. As a result, immunodiagnostics finds extensive applications across hospitals, clinical laboratories and research and academic institutes.

Immunodiagnostics Market Trends:

The increasing prevalence of chronic medical ailments and infections among the masses is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. There is also an escalating awareness among the consumers regarding the available treatment alternatives for ailments, such as hepatitis B, diabetes and cancer, which is positively impacting the demand for immunodiagnostics kits, assays and analyzers. Additionally, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market toward growth. These advanced point-of-care testing (POCT) systems offer enhanced diagnostic facilities for sepsis, acute cardiac infractions and other medical disorders with higher mortality rates. Other factors, including the increasing requirement for personalized medicines among the masses, along with extensive improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global immunodiagnostics market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

  • Reagents
  • Instruments
  • Software and Services

Breakup by Technology:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Others

Breakup by Application:

  • Infectious Diseases
  • Oncology and Endocrinology
  • Hepatitis and Retrovirus
  • Bone and Mineral
  • Autoimmunity
  • Cardiac Biomarker
  • Others

Breakup by End User:

  • Hospitals
  • Clinical Laboratories
  • Academic and Research Centers
  • Pharmaceutical and Biotechnology Industry
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arkray Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Immunodiagnostic Systems Holdings PLC, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the global immunodiagnostics market?
  • 2.What is the expected growth rate of the global immunodiagnostics market during 2026-2034?
  • 3.What are the key factors driving the global immunodiagnostics market?
  • 4.What has been the impact of COVID-19 on the global immunodiagnostics market?
  • 5.What is the breakup of the global immunodiagnostics market based on the application?
  • 6.What is the breakup of the global immunodiagnostics market based on the end user?
  • 7.What are the key regions in the global immunodiagnostics market?
  • 8.Who are the key players/companies in the global immunodiagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunodiagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Enzyme-Linked Immunosorbent Assay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemiluminescence Immunoassay
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Fluorescent Immunoassay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Radioimmunoassay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Rapid Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology and Endocrinology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hepatitis and Retrovirus
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Bone and Mineral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Autoimmunity
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Cardiac Biomarker
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pharmaceutical and Biotechnology Industry
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arkray Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Immunodiagnostic Systems Holdings PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunodiagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Immunodiagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Immunodiagnostics Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Immunodiagnostics Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Immunodiagnostics Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Immunodiagnostics Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Immunodiagnostics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Immunodiagnostics (Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Immunodiagnostics (Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Immunodiagnostics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Immunodiagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Immunodiagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Immunodiagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Immunodiagnostics (Enzyme-Linked Immunosorbent Assay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Immunodiagnostics (Enzyme-Linked Immunosorbent Assay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Immunodiagnostics (Chemiluminescence Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Immunodiagnostics (Chemiluminescence Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Immunodiagnostics (Fluorescent Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Immunodiagnostics (Fluorescent Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Immunodiagnostics (Radioimmunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Immunodiagnostics (Radioimmunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Immunodiagnostics (Rapid Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Immunodiagnostics (Rapid Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Immunodiagnostics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Immunodiagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Immunodiagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Immunodiagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Immunodiagnostics (Oncology and Endocrinology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Immunodiagnostics (Oncology and Endocrinology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Immunodiagnostics (Hepatitis and Retrovirus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Immunodiagnostics (Hepatitis and Retrovirus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Immunodiagnostics (Bone and Mineral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Immunodiagnostics (Bone and Mineral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Immunodiagnostics (Autoimmunity) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Immunodiagnostics (Autoimmunity) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Immunodiagnostics (Cardiac Biomarker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Immunodiagnostics (Cardiac Biomarker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Immunodiagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Immunodiagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Immunodiagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Immunodiagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Immunodiagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Immunodiagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Immunodiagnostics (Academic and Research Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Immunodiagnostics (Academic and Research Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Immunodiagnostics (Pharmaceutical and Biotechnology Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Immunodiagnostics (Pharmaceutical and Biotechnology Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Immunodiagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Immunodiagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: North America: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: North America: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United States: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United States: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Canada: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Canada: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Asia-Pacific: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Asia-Pacific: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: China: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: China: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Japan: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Japan: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: India: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: India: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: South Korea: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: South Korea: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Australia: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Australia: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Indonesia: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Indonesia: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Europe: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Europe: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Germany: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Germany: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: France: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: France: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: United Kingdom: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: United Kingdom: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Italy: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Italy: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Spain: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Spain: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Russia: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Russia: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Latin America: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Latin America: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Brazil: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Brazil: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Mexico: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Mexico: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Others: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Others: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Middle East and Africa: Immunodiagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Middle East and Africa: Immunodiagnostics Market: Breakup by Country (in %), 2025
  • Figure 98: Middle East and Africa: Immunodiagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Global: Immunodiagnostics Industry: SWOT Analysis
  • Figure 100: Global: Immunodiagnostics Industry: Value Chain Analysis
  • Figure 101: Global: Immunodiagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunodiagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Immunodiagnostics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Immunodiagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Immunodiagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Immunodiagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Immunodiagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Immunodiagnostics Market: Competitive Structure
  • Table 8: Global: Immunodiagnostics Market: Key Players